Results 71 to 80 of about 9,874 (219)
European Journal of Haematology, Volume 116, Issue 4, Page 336-349, April 2026.ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot +3 more
wiley +1 more source
F1000Research, 2017 The incidence of whooping cough in the US has been rising slowly since the 1970s, but the pace of this has accelerated sharply since acellular pertussis vaccines replaced the earlier whole cell vaccines in the late 1990s. A similar trend occurred in many
Christopher Gill +2 more
doaj +1 more source
Advanced Healthcare Materials, Volume 15, Issue 9, 6 March 2026.Norbornene‐functionalized alginate is crosslinked with a di‐thiolated peptide sequence cleavable by cell‐secreted matrix metalloproteinases and decorated with cell‐adhesion peptides upon exposure to UV. Thyroid follicles, endometrial and intestinal organoids are encapsulated in a gentle manner with high cell viability and correct phenotype ...
Julia Fernández‐Pérez +8 more
wiley +1 more source
Health Policy and Technological Change: Evidence from the Vaccine Industry [PDF]
Rapid technological progress has been a defining feature of the medical sector over the last century, yet we know little about the determinants of the development of these new technologies.
Amy Finkelstein
core
, 2023 ObjectiveTo analyze the occurrence of suspected adverse events following immunization （AEFI） after changing the priority vaccination sites of the adsorbed acellular diphtherior-pertussis-tetanus vaccine （hereinafter referred to as DPT vaccine）， so as to ...
LIU Cunfang +3 more
core +1 more source
, 2012 Although the safety profile of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis Tdap vaccines in adolescents and adults has been documented, few data have reported about their adverse events in children.
魏嵩璽;李翠鳳;張鑾英 +1 more
core +1 more source
, 2014 OBJECTIVES To assess the effectiveness of three, four and five doses of acellular pertussis vaccine against pertussis notification for children aged 1 - < 4 years and 5 - < 12 years, and the effectiveness of three doses of acellular pertussis vaccine ...
Ware, Robert S. +16 more
core +1 more source
Журнал микробиологии, эпидемиологии и иммунобиологии, 2016 Aim. Study cytokine status in mice immunized with vaccines containing acellular pertussis component. Materials and methods. Vaccines developed in Mechnikov RIVS - acellular pertussis vaccine (aPV) and adsorbed pertussis-diphtheria-tetanus vaccine (aDTaP),
E. M. Zaitsev +5 more
doaj +1 more source
, 2011 Despite more than 50 years of vaccination, disease caused by the bacterium Bordetella pertussis persists, with rates increasing in industrialized countries over the past decade.
Jennifer A. Maynard +11 more
core +1 more source
BMC Infectious Diseases, 2006 Background In Australia two acellular Bordetella pertussis vaccines have replaced the use of a whole cell vaccine. Both of the licensed acellular vaccines contain the following three components; pertussis toxoid, pertussis filamentous haemagglutinin and ...
Slack Andrew T, Byrne Shane
doaj +1 more source